FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline Post author:PacConAdmin Post published:May 8, 2025 Post category:Uncategorized Post comments:0 Comments FDA announced an aggressive timeline to scale AI across all centers by June 30. Source: FDA Press Releases Tags: aaps Read more articles Previous PostFDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities Next PostFDA Approves Three Food Colors from Natural Sources You Might Also Like First OTC Continuous Glucose Monitor Cleared by the FDA March 6, 2024 FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices February 5, 2025 Two Medical Device Draft Guidances Detail Q-Submission Process, Thermal Effects March 14, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices February 5, 2025